| Year |
Citation |
Score |
| 2024 |
Morales AE, Gumenick R, Genovese CM, Jang YY, Ouedraogo A, Ibáñez de Garayo M, Pannellini T, Patel S, Bott ME, Alvarez J, Mun SS, Totonchy J, Gautam A, Delgado de la Mora J, Chang S, ... ... Cesarman E, et al. Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP. Plos Pathogens. 20: e1011881. PMID 38190392 DOI: 10.1371/journal.ppat.1011881 |
0.375 |
|
| 2023 |
Singh B, Dopkins N, Fei T, Marston JL, Michael S, Reyes-Gopar H, Curty G, Heymann JJ, Chadburn A, Martin P, Leal FE, Cesarman E, Nixon DF, Bendall ML. Locus specific human endogenous retroviruses reveal new lymphoma subtypes. Biorxiv : the Preprint Server For Biology. PMID 37333202 DOI: 10.1101/2023.06.08.544208 |
0.402 |
|
| 2022 |
Müller Coan BG, Cesarman E, Acencio ML, Elgui de Oliveira D. Latent Membrane Protein 1 (LMP1) from Epstein-Barr Virus (EBV) Strains M81 and B95.8 Modulate miRNA Expression When Expressed in Immortalized Human Nasopharyngeal Cells. Genes. 13. PMID 35205397 DOI: 10.3390/genes13020353 |
0.303 |
|
| 2021 |
Méndez-Solís O, Bendjennat M, Naipauer J, Theodoridis PR, Ho JJD, Verdun RE, Hare JM, Cesarman E, Lee S, Mesri EA. Kaposi's sarcoma herpesvirus activates the hypoxia response to usurp HIF2α-dependent translation initiation for replication and oncogenesis. Cell Reports. 37: 110144. PMID 34965440 DOI: 10.1016/j.celrep.2021.110144 |
0.335 |
|
| 2021 |
Cesarman E, Chadburn A, Rubinstein PG. KSHV/HHV8-mediated hematologic diseases. Blood. PMID 34479367 DOI: 10.1182/blood.2020005470 |
0.383 |
|
| 2021 |
Guasparri I, Keller SA, Cesarman E. Retraction: KSHV vFLIP Is Essential for the Survival of Infected Lymphoma Cells. The Journal of Experimental Medicine. 218. PMID 33599700 DOI: 10.1084/jem.2003146702062021r |
0.724 |
|
| 2020 |
Scholze H, Stephenson RE, Reynolds R, Shah S, Puri R, Butler SD, Trujillo-Alonso V, Teater MR, van Besien H, Gibbs-Curtis D, Ueno H, Parvin S, Letai A, Mathew S, Singh A, ... Cesarman E, et al. Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes. Blood Advances. 4: 5226-5231. PMID 33104794 DOI: 10.1182/bloodadvances.2020002580 |
0.322 |
|
| 2020 |
Medina MV, D Agostino A, Ma Q, Eroles P, Cavallin L, Chiozzini C, Sapochnik D, Cymeryng C, Hyjek E, Cesarman E, Naipauer J, Mesri EA, Coso OA. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma. Plos Pathogens. 16: e1009006. PMID 33057440 DOI: 10.1371/journal.ppat.1009006 |
0.314 |
|
| 2020 |
Ramos JC, Sparano JA, Chadburn A, Reid EG, Ambinder RF, Siegel ER, Moore PC, Rubinstein PG, Durand C, Cesarman E, Aboulafia DM, Baiocchi RA, Ratner L, Kaplan LD, Capoferri AA, et al. Impact of Myc in HIV-associated Non-Hodgkin Lymphomas Treated with EPOCH, and Outcomes with Vorinostat (AMC075 Trial). Blood. PMID 32430507 DOI: 10.1182/Blood.2019003959 |
0.369 |
|
| 2020 |
Guo R, Zhang Y, Teng M, Jiang C, Schineller M, Zhao B, Doench JG, O'Reilly RJ, Cesarman E, Giulino-Roth L, Gewurz BE. DNA methylation enzymes and PRC1 restrict B-cell Epstein-Barr virus oncoprotein expression. Nature Microbiology. PMID 32424339 DOI: 10.1038/S41564-020-0724-Y |
0.485 |
|
| 2020 |
Sadek J, Wuo MG, Rooklin D, Hauenstein A, Hong SH, Gautam A, Wu H, Zhang Y, Cesarman E, Arora PS. Modulation of virus-induced NF-κB signaling by NEMO coiled coil mimics. Nature Communications. 11: 1786. PMID 32286300 DOI: 10.1038/S41467-020-15576-3 |
0.364 |
|
| 2020 |
Dalton T, Doubrovina E, Pankov D, Reynolds RC, Scholze H, Selvakumar A, Vizconde T, Savalia B, Dyomin V, Weigel C, Oakes CC, Alonso A, Elemento O, Pan H, Phillip JM, ... ... Cesarman E, et al. Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to viral directed immunotherapy. Blood. PMID 32157281 DOI: 10.1182/Blood.2019004126 |
0.459 |
|
| 2020 |
Sparano JA, Lee JY, Kaplan LD, Ramos JC, Ambinder RF, Wachsman W, Aboulafia D, Noy A, Henry DH, Ratner L, Cesarman E, Chadburn A, Mitsuyasu R. Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV- associated, B-cell non-Hodgkin's lymphoma. Haematologica. PMID 32107337 DOI: 10.3324/Haematol.2019.243386 |
0.356 |
|
| 2020 |
Ruder B, Günther C, Stürzl M, Neurath MF, Cesarman E, Ballon G, Becker C. Viral FLIP blocks Caspase-8 driven apoptosis in the gut in vivo. Plos One. 15: e0228441. PMID 31999759 DOI: 10.1371/Journal.Pone.0228441 |
0.418 |
|
| 2019 |
Yusufova N, Teater MR, Soshnev A, Kloetgen A, Osunsade A, Conway J, Doane A, Skoultchi A, Tsirigos A, David Y, Allis CD, Cesarman E, Melnick A. Histone 1 Mutations Drive Lymphomagenesis By Inducing Primitive Stem Cell Functions and Epigenetic Instructions through Profound 3D Re-Organization of the B-Cell Genome. Blood. 134: 23. PMID 31723979 DOI: 10.1182/Blood-2019-127774 |
0.309 |
|
| 2019 |
Cesarman E, Roshal M, Reichel J, Florian W, Binder B, Zairis S, Sadek J, Brody J, Rabadan R, Dave S. RNA Sequencing of Hodgkin Lymphoma Reed-Sternberg Cells Uncovers a Plasma Cell Signature and Escape from NK Cell Recognition Blood. 134: 549-549. DOI: 10.1182/Blood-2019-131163 |
0.481 |
|
| 2019 |
Ramos JC, Sparano J, Moore PC, Siegel E, Lee JY, Reid EG, Ambinder RF, Chadburn A, Rubinstein PG, Durand C, Cesarman E, Ratner L, Baiocchi RA, Aboulafia DM, Kaplan LD, et al. A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatment Interval (DTI) and Pre-Protocol Systemic Therapy on Outcomes Blood. 134: 1588-1588. DOI: 10.1182/Blood-2019-129687 |
0.373 |
|
| 2019 |
Yamshon S, Cantu MD, Cesarman E, Rutherford SC, Chadburn A, Crane GM. Non-Destructive Post-Transplant Lymphoproliferative Disorder Shows Distinct Clinical Features with HHV-6 Reactivation in a Subset Blood. 134: 2792-2792. DOI: 10.1182/Blood-2019-128374 |
0.326 |
|
| 2019 |
Gibbs D, Van Besien H, Regan S, Singh A, Teater M, Cesarman E, Melnick A, Roth LG. Combined EZH2 and BCL2 Inhibitors As Precision Therapy for Genetically Defined DLBCL Subtypes Blood. 134: 304-304. DOI: 10.1182/Blood-2019-126790 |
0.403 |
|
| 2019 |
Rubinstein PG, Moore PC, Bimali M, Chadburn A, Cesarman E, Rudek M, Ratner L, Ambinder RF, Henry DH, Barta SK, Ghesquieres H, Coppo P, Delobel P, Boue F, Galicier L, et al. Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085 Blood. 134: 130-130. DOI: 10.1182/Blood-2019-126787 |
0.333 |
|
| 2018 |
Reid EG, Looney D, Maldarelli F, Noy A, Henry D, Aboulafia D, Ramos JC, Sparano J, Ambinder RF, Lee J, Cesarman E, Yahyaei S, Mitsuyasu R, Wachsman W. Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas. Blood Advances. 2: 3618-3626. PMID 30573564 DOI: 10.1182/Bloodadvances.2018022095 |
0.355 |
|
| 2018 |
Ruder B, Murtadak V, Stürzl M, Wirtz S, Distler U, Tenzer S, Mahapatro M, Greten FR, Hu Y, Neurath MF, Cesarman E, Ballon G, Günther C, Becker C. Chronic intestinal inflammation in mice expressing viral Flip in epithelial cells. Mucosal Immunology. PMID 30104627 DOI: 10.1038/S41385-018-0068-6 |
0.404 |
|
| 2018 |
Ayers LW, Barbachano-Guerrero A, McAllister SC, Ritchie JA, Asiago-Reddy E, Bartlett LC, Cesarman E, Wang D, Rochford R, Martin JN, King CA. Mast cell activation and KSHV infection in Kaposi sarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30084838 DOI: 10.1158/1078-0432.Ccr-18-0873 |
0.411 |
|
| 2018 |
Totonchy J, Osborn JM, Chadburn A, Nabiee R, Argueta L, Mikita G, Cesarman E. KSHV induces immunoglobulin rearrangements in mature B lymphocytes. Plos Pathogens. 14: e1006967. PMID 29659614 DOI: 10.1371/Journal.Ppat.1006967 |
0.453 |
|
| 2018 |
Ramos JC, Sparano JA, Rudek MA, Moore PC, Cesarman E, Reid EG, Henry D, Ratner L, Aboulafia D, Lee JY, Ambinder RF, Mitsuyasu R, Noy A. Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075). Clinical Lymphoma, Myeloma & Leukemia. PMID 29426719 DOI: 10.1016/J.Clml.2018.01.004 |
0.392 |
|
| 2017 |
McHugh D, Caduff N, Barros MHM, Rämer PC, Raykova A, Murer A, Landtwing V, Quast I, Styles CT, Spohn M, Fowotade A, Delecluse HJ, Papoudou-Bai A, Lee YM, Kim JM, ... ... Cesarman E, et al. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression. Cell Host & Microbe. 22: 61-73.e7. PMID 28704654 DOI: 10.1016/J.Chom.2017.06.009 |
0.48 |
|
| 2017 |
Reichel JB, McCormick J, Fromm JR, Elemento O, Cesarman E, Roshal M. Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma. Journal of Visualized Experiments : Jove. PMID 28654052 DOI: 10.3791/54399 |
0.379 |
|
| 2017 |
Giulino-Roth L, Van Besien HJ, Dalton T, Totonchy JE, Rodina A, Taldone T, Bolaender A, Erdjument-Bromage H, Sadek J, Chadburn A, Barth MJ, Dela Cruz FS, Rainey A, Kung AL, Chiosis G, ... Cesarman E, et al. Inhibition of Hsp90 suppresses PI3K/AKT/mTOR signaling and has antitumor activity in Burkitt lymphoma. Molecular Cancer Therapeutics. PMID 28619753 DOI: 10.1158/1535-7163.Mct-16-0848 |
0.377 |
|
| 2017 |
Nayar U, Sadek J, Reichel J, Hernandez-Hopkins D, Akar G, Barelli PJ, Sahai MA, Zhou H, Totonchy J, Jayabalan D, Niesvizky R, Guasparri I, Hassane D, Liu Y, Sei S, ... ... Cesarman E, et al. Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies. The Journal of Clinical Investigation. PMID 28504647 DOI: 10.1172/Jci83936 |
0.707 |
|
| 2017 |
Müller-Coan BG, Cesarman E, Oliveira DED. Abstract 5756: Effects of Epstein-Barr virus latent membrane protein 1 (LMP1) on cell invasiveness and expression of endogenous microRNAs in human cellsin vitro Cancer Research. 77: 5756-5756. DOI: 10.1158/1538-7445.Am2017-5756 |
0.449 |
|
| 2017 |
Sadek J, Nayar U, Reichel J, Totonchy J, Sei S, Shoemaker R, Warren D, Elemento O, Kaye K, Cesarman E. Abstract 5110: A novel nucleoside analog therapeutically active against plasma cell malignancies and other ADK-expressing cancers including colon and pancreatic adenocarcinomas Cancer Research. 77: 5110-5110. DOI: 10.1158/1538-7445.Am2017-5110 |
0.415 |
|
| 2017 |
Roshal M, Reichel J, Wagner F, Zairis S, Sadek J, Brody J, Elemento O, Rabadan R, Dave S, Cesarman E. FULL TRANSCRIPTOME SEQUENCING OF SORTED HODGKIN AND REED-STERNBERG CELLS REVEALS PLASMACYTIC DIFFERENTIATION: INSIGHTS INTO MECHANISMS OF ONCOGENESIS AND IMMUNE EVASION Hematological Oncology. 35: 104-105. DOI: 10.1002/Hon.2437_93 |
0.314 |
|
| 2016 |
Rodina A, Wang T, Yan P, Gomes ED, Dunphy MP, Pillarsetty N, Koren J, Gerecitano JF, Taldone T, Zong H, Caldas-Lopes E, Alpaugh M, Corben A, Riolo M, Beattie B, ... ... Cesarman E, et al. The epichaperome is an integrated chaperome network that facilitates tumour survival. Nature. PMID 27706135 DOI: 10.1038/Nature19807 |
0.302 |
|
| 2016 |
Totonchy J, Cesarman E. Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy? Current Opinion in Virology. 20: 71-77. PMID 27665065 DOI: 10.1016/J.Coviro.2016.09.001 |
0.329 |
|
| 2016 |
Snodgrass R, Gardner A, Jiang L, Fu C, Cesarman E, Erickson D. KS-Detect - Validation of Solar Thermal PCR for the Diagnosis of Kaposi's Sarcoma Using Pseudo-Biopsy Samples. Plos One. 11: e0147636. PMID 26799834 DOI: 10.1371/Journal.Pone.0147636 |
0.319 |
|
| 2015 |
Schulz TF, Cesarman E. Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis. Current Opinion in Virology. 14: 116-28. PMID 26431609 DOI: 10.1016/J.Coviro.2015.08.016 |
0.452 |
|
| 2015 |
Noy A, Lee JY, Cesarman E, Ambinder R, Baiocchi R, Reid E, Ratner L, Wagner-Johnston N, Kaplan L. AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. Blood. 126: 160-6. PMID 25957391 DOI: 10.1182/Blood-2015-01-623900 |
0.323 |
|
| 2015 |
Arvey A, Ojesina AI, Pedamallu CS, Ballon G, Jung J, Duke F, Leoncini L, De Falco G, Bressman E, Tam W, Chadburn A, Meyerson M, Cesarman E. The tumor virus landscape of AIDS-related lymphomas. Blood. 125: e14-22. PMID 25827832 DOI: 10.1182/Blood-2014-11-599951 |
0.427 |
|
| 2015 |
Ballon G, Akar G, Cesarman E. Systemic expression of Kaposi sarcoma herpesvirus (KSHV) Vflip in endothelial cells leads to a profound proinflammatory phenotype and myeloid lineage remodeling in vivo. Plos Pathogens. 11: e1004581. PMID 25607954 DOI: 10.1371/Journal.Ppat.1004581 |
0.367 |
|
| 2015 |
Reichel J, Chadburn A, Rubinstein PG, Giulino-Roth L, Tam W, Liu Y, Gaiolla R, Eng K, Brody J, Inghirami G, Carlo-Stella C, Santoro A, Rahal D, Totonchy J, Elemento O, ... Cesarman E, et al. Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood. 125: 1061-72. PMID 25488972 DOI: 10.1182/Blood-2014-11-610436 |
0.452 |
|
| 2015 |
Ma SD, Xu X, Plowshay J, Ranheim EA, Burlingham WJ, Jensen JL, Asimakopoulos F, Tang W, Gulley ML, Cesarman E, Gumperz JE, Kenney SC. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis. The Journal of Clinical Investigation. 125: 304-15. PMID 25485679 DOI: 10.1172/Jci76357 |
0.474 |
|
| 2015 |
Giulino Roth L, van Besien H, Rodina A, Taldone T, Erdjument-Bromage H, Barth MJ, Chiosis G, Cesarman E. Targeting the Hsp90 Oncoproteome in Burkitt Lymphoma Blood. 126: 592-592. DOI: 10.1182/Blood.V126.23.592.592 |
0.395 |
|
| 2015 |
Nayar U, Sadek J, Reichel JB, Bunn D, Hernandez-Hopkins D, Barelli P, Sahai M, Totonchy J, Shizuko S, Shoemaker R, Warren D, Elemento O, Kaye K, Cesarman E. Exquisite Sensitivity of Plasma Cell Malignancies to a Novel Nucleoside Analog Is Mediated By Overexpressed Adenosine Kinase Blood. 126: 1812-1812. DOI: 10.1182/Blood.V126.23.1812.1812 |
0.705 |
|
| 2015 |
Reichel J, Brody J, Elemento O, Rabadan R, Cesarman E. Abstract 4750: Transcriptome sequencing of the Reed-Sternberg cells of classical Hodgkin lymphoma Cancer Research. 75: 4750-4750. DOI: 10.1158/1538-7445.Am2015-4750 |
0.415 |
|
| 2015 |
Nayar U, Reichel J, Sadek J, Hernandez-Hopkins D, Akar G, Zhou H, Sahai MA, Barelli P, Guasparri I, Totonchy J, Hassane D, Sei S, Shoemaker RH, Warren JD, Elemento O, ... ... Cesarman E, et al. Abstract 4496: Genomics-based resistome analysis revealed endogenous adenosine kinase levels as a chief determinant of specificity for a novel nucleoside analog lymphoma inhibitor Cancer Research. 75: 4496-4496. DOI: 10.1158/1538-7445.Am2015-4496 |
0.609 |
|
| 2015 |
Schulz TF, Cesarman E. Kaposi Sarcoma-associated Herpesvirus: Mechanisms of oncogenesis Current Opinion in Virology. 14: 116-128. DOI: 10.1016/j.coviro.2015.08.016 |
0.345 |
|
| 2014 |
Pekkonen P, Järviluoma A, Zinovkina N, Cvrljevic A, Prakash S, Westermarck J, Evan GI, Cesarman E, Verschuren EW, Ojala PM. KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo. Cell Cycle (Georgetown, Tex.). 13: 3670-84. PMID 25483078 DOI: 10.4161/15384101.2014.964118 |
0.454 |
|
| 2014 |
Vogel MJ, Xie L, Guan H, Tooze RM, Maier T, Kostezka U, Maier HJ, Holzmann K, Chan FC, Steidl C, Reichel JB, Weitzer CD, Gehringer F, Kick AB, Cesarman E, et al. FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma. Blood. 124: 3118-29. PMID 25232062 DOI: 10.1182/Blood-2014-07-590570 |
0.465 |
|
| 2014 |
Cesarman E. How do viruses trick B cells into becoming lymphomas? Current Opinion in Hematology. 21: 358-68. PMID 24886824 DOI: 10.1097/Moh.0000000000000060 |
0.452 |
|
| 2014 |
Cesarman E. Gammaherpesviruses and lymphoproliferative disorders. Annual Review of Pathology. 9: 349-72. PMID 24111911 DOI: 10.1146/Annurev-Pathol-012513-104656 |
0.447 |
|
| 2014 |
Ramos JC, Sparano J, Moore P, Lee JY, Rudek MA, Ambinder RF, Cesarman E, Noy A, Mitsuyasu RT. AMC075: The Combination of Vorinostat with Chemotherapy and Rituximab Is Tolerable and Feasible in HIV-Related B-Cell Non-Hodgkin’s Lymphoma with High-Risk Features Blood. 124: 4473-4473. DOI: 10.1182/Blood.V124.21.4473.4473 |
0.338 |
|
| 2014 |
Giulino-Roth L, Reichel J, Teruya-Feldstein J, Tam W, Tam Y, Roshal M, Cesarman E. Beta-2 Microglobulin (B2 M) Genomic Alterations and Absent Protein Expression in Pediatric and Adolescent Classical Hodgkin Lymphoma Klinische PäDiatrie. 226. DOI: 10.1055/S-0034-1371104 |
0.332 |
|
| 2013 |
Wong LY, Brulois K, Toth Z, Inn KS, Lee SH, O'Brien K, Lee H, Gao SJ, Cesarman E, Ensser A, Jung JU. The product of Kaposi's sarcoma-associated herpesvirus immediate early gene K4.2 regulates immunoglobulin secretion and calcium homeostasis by interacting with and inhibiting pERP1. Journal of Virology. 87: 12069-79. PMID 23986581 DOI: 10.1128/Jvi.01900-13 |
0.447 |
|
| 2013 |
Nayar U, Lu P, Goldstein RL, Vider J, Ballon G, Rodina A, Taldone T, Erdjument-Bromage H, Chomet M, Blasberg R, Melnick A, Cerchietti L, Chiosis G, Wang YL, Cesarman E. Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies. Blood. 122: 2837-47. PMID 23943653 DOI: 10.1182/Blood-2013-01-479972 |
0.699 |
|
| 2013 |
Cesarman E. Pathology of lymphoma in HIV. Current Opinion in Oncology. 25: 487-94. PMID 23942293 DOI: 10.1097/01.Cco.0000432525.70099.A4 |
0.33 |
|
| 2013 |
Byun M, Ma CS, Akçay A, Pedergnana V, Palendira U, Myoung J, Avery DT, Liu Y, Abhyankar A, Lorenzo L, Schmidt M, Lim HK, Cassar O, Migaud M, Rozenberg F, ... ... Cesarman E, et al. Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. The Journal of Experimental Medicine. 210: 1743-59. PMID 23897980 DOI: 10.1084/Jem.20130592 |
0.401 |
|
| 2013 |
Levine AM, Noy A, Lee JY, Tam W, Ramos JC, Henry DH, Parekh S, Reid EG, Mitsuyasu R, Cooley T, Dezube BJ, Ratner L, Cesarman E, Tulpule A. Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 58-64. PMID 23169503 DOI: 10.1200/Jco.2012.42.4648 |
0.322 |
|
| 2013 |
Reichel JB, Eng K, Elemento O, Cesarman E, Roshal M. Exome Sequencing Of Purified Hodgkin Reed-Sternberg Cells Reveals Recurrent Somatic Mutations In Genes Responsible For Antigen Presentation, Chromosome Integrity, Transcriptional Regulation and Protein Ubiquitination Blood. 122: 625-625. DOI: 10.1182/Blood.V122.21.625.625 |
0.384 |
|
| 2013 |
Kanakry JA, Shamay M, Kasamon YL, Li H, Gascoyne RD, Gordon LI, Noy A, Cesarman E, Lee JY, Horning SJ, Ambinder RF. Characterizing The CpG Methylation Of Epstein-Barr Virus DNA In The Plasma Of Patients With Hodgkin Lymphoma and HIV-Associated Burkitt Lymphoma Blood. 122: 4232-4232. DOI: 10.1182/Blood.V122.21.4232.4232 |
0.315 |
|
| 2013 |
Rubinstein PG, Sreenivasappa S, Messinger M, Petrich AM, Moreira J, Bryan LJ, Angelova V, Gupta S, Noy A, Sumpter I, Cesarman E, Chadburn A. Microenvironment Assessment, Disease Characteristics and Prognosis In HIV-Associated (HIV-cHL) and HIV-Negative Classical Hodgkin Lymphoma: The Influence Of Epstein Barr Virus (EBV) Blood. 122: 2996-2996. DOI: 10.1182/Blood.V122.21.2996.2996 |
0.315 |
|
| 2012 |
Giulino-Roth L, Wang K, MacDonald TY, Mathew S, Tam Y, Cronin MT, Palmer G, Lucena-Silva N, Pedrosa F, Pedrosa M, Teruya-Feldstein J, Bhagat G, Alobeid B, Leoncini L, Bellan C, ... ... Cesarman E, et al. Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes. Blood. 120: 5181-4. PMID 23091298 DOI: 10.1182/Blood-2012-06-437624 |
0.333 |
|
| 2012 |
Cooper N, Stasi R, Cunningham-Rundles S, Cesarman E, McFarland JG, Bussel JB. Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia. British Journal of Haematology. 158: 539-47. PMID 22775462 DOI: 10.1111/J.1365-2141.2012.09184.X |
0.369 |
|
| 2012 |
Cesarman E. Viral lymphomas: can antivirals be used to treat cancer? Hematology (Amsterdam, Netherlands). 17: S83-6. PMID 22507788 DOI: 10.1179/102453312X13336169155899 |
0.441 |
|
| 2012 |
Krown SE, Roy D, Lee JY, Dezube BJ, Reid EG, Venkataramanan R, Han K, Cesarman E, Dittmer DP. Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study. Journal of Acquired Immune Deficiency Syndromes (1999). 59: 447-54. PMID 22067664 DOI: 10.1097/Qai.0B013E31823E7884 |
0.343 |
|
| 2012 |
Cesarman E. Molecular Detection of Kaposi's Sarcoma-Associated Herpesvirus/ Human Herpesvirus-8. Methods in Molecular Medicine. 49: 331-6. PMID 21370151 DOI: 10.1385/1-59259-081-0:331 |
0.388 |
|
| 2012 |
Hassane D, Padilla J, Kim R, Giulino L, Matthew S, Tam W, Chadburn A, Barouk S, Adebamowo C, Leoncini L, Shet T, Rubin MA, Cesarman E. Gene expression profiling using formalin-fixed paraffin-embedded primary specimens of AIDS-related Lymphomas Infectious Agents and Cancer. 7. DOI: 10.1186/1750-9378-7-S1-O21 |
0.332 |
|
| 2012 |
Guasparri I, Hassane DC, Roshal M, Cesarman E. The Viral Oncoprotein vFLIP Encoded by KSHV/HHV-8 Is Responsible for the Unique Transcriptional Signature and Phenotypic Features of Primary Effusion Lymphoma Blood. 120: 900-900. DOI: 10.1182/Blood.V120.21.900.900 |
0.494 |
|
| 2012 |
Roth LG, Wang K, MacDonald T, Mathew S, Tam Y, Cronin MT, Palmer G, Lucena-Silva N, Pedrosa F, Pedrosa M, Teruya-Feldstein J, Bhagat G, Alobeid B, Leoncini L, Bellan C, ... ... Cesarman E, et al. Novel Genomic Alterations in MCL1 and ARID1A Identified in Pediatric Burkitt Lymphoma Using Targeted High-Throughput Sequencing Blood. 120: 899-899. DOI: 10.1182/Blood.V120.21.899.899 |
0.367 |
|
| 2012 |
Nayar U, Akar G, Shoemaker RH, Sei S, Cesarman E. Identification of a Novel Inhibitor That Selectively Targets NF-κB Activity in KSHV-Infected Lymphoma Cells Blood. 120: 160-160. DOI: 10.1182/Blood.V120.21.160.160 |
0.711 |
|
| 2012 |
Nayar U, Lu P, Vider J, Goldstein RL, Ballon G, Cerchietti L, Chiosis G, Wang YL, Cesarman E. Abstract 4829: A purine scaffold Hsp90 inhibitor has antitumor activity in KSHV-associated malignancies by suppressing vFLIP Cancer Research. 72: 4829-4829. DOI: 10.1158/1538-7445.Am2012-4829 |
0.715 |
|
| 2011 |
Mesri EA, Cesarman E. Kaposi's sarcoma herpesvirus oncogenesis is a notch better in 3D. Cell Host & Microbe. 10: 529-31. PMID 22177556 DOI: 10.1016/J.Chom.2011.11.008 |
0.408 |
|
| 2011 |
Cesarman E. Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cancer Letters. 305: 163-74. PMID 21493001 DOI: 10.1016/J.Canlet.2011.03.003 |
0.398 |
|
| 2011 |
Krown SE, Dittmer DP, Cesarman E. Pilot study of oral valganciclovir therapy in patients with classic Kaposi sarcoma. The Journal of Infectious Diseases. 203: 1082-6. PMID 21450998 DOI: 10.1093/Infdis/Jiq177 |
0.36 |
|
| 2011 |
Giulino L, Mathew S, Ballon G, Chadburn A, Barouk S, Antonicelli G, Leoncini L, Liu YF, Gogineni S, Tam W, Cesarman E. A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma. Blood. 117: 4852-4. PMID 21406721 DOI: 10.1182/Blood-2010-10-310995 |
0.347 |
|
| 2011 |
Ballon G, Chen K, Perez R, Tam W, Cesarman E. Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice. The Journal of Clinical Investigation. 121: 1141-53. PMID 21339646 DOI: 10.1172/Jci44417 |
0.503 |
|
| 2011 |
Ruan J, Martin P, Furman RR, Lee SM, Cheung K, Vose JM, Lacasce A, Morrison J, Elstrom R, Ely S, Chadburn A, Cesarman E, Coleman M, Leonard JP. Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 690-7. PMID 21189393 DOI: 10.1200/Jco.2010.31.1142 |
0.423 |
|
| 2011 |
Sun SC, Cesarman E. NF-κB as a target for oncogenic viruses. Current Topics in Microbiology and Immunology. 349: 197-244. PMID 20845110 DOI: 10.1007/82_2010_108 |
0.415 |
|
| 2010 |
Mesri EA, Cesarman E, Boshoff C. Kaposi's sarcoma and its associated herpesvirus. Nature Reviews. Cancer. 10: 707-19. PMID 20865011 DOI: 10.1038/Nrc2888 |
0.455 |
|
| 2010 |
Luan SL, Boulanger E, Ye H, Chanudet E, Johnson N, Hamoudi RA, Bacon CM, Liu H, Huang Y, Said J, Chu P, Clemen CS, Cesarman E, Chadburn A, Isaacson PG, et al. Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration. The Journal of Pathology. 222: 166-79. PMID 20690162 DOI: 10.1002/Path.2752 |
0.333 |
|
| 2010 |
de Oliveira DE, Ballon G, Cesarman E. NF-kappaB signaling modulation by EBV and KSHV. Trends in Microbiology. 18: 248-57. PMID 20452220 DOI: 10.1016/J.Tim.2010.04.001 |
0.389 |
|
| 2010 |
Carbone A, Cesarman E, Gloghini A, Drexler HG. Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines. Aids (London, England). 24: 479-90. PMID 20051807 DOI: 10.1097/Qad.0B013E3283365395 |
0.48 |
|
| 2010 |
Sparano JA, Lee JY, Kaplan LD, Levine AM, Ramos JC, Ambinder RF, Wachsman W, Aboulafia D, Noy A, Henry DH, Von Roenn J, Dezube BJ, Remick SC, Shah MH, Leichman L, ... ... Cesarman E, et al. Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood. 115: 3008-16. PMID 20023215 DOI: 10.1182/Blood-2009-08-231613 |
0.366 |
|
| 2010 |
Giulino L, Matthew S, Tam W, Chadburn A, Ballon G, Barouk S, Antonicelli G, Leoncini L, Cesarman E. TNFAIP3(A20) genetic alterations in AIDS-related lymphomas Infectious Agents and Cancer. 5. DOI: 10.1186/1750-9378-5-S1-A82 |
0.459 |
|
| 2010 |
Nayar U, Lu P, Vider J, Cerchietti L, Chiosis G, Wang L, Blasberg R, Cesarman E. Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma Infectious Agents and Cancer. 5. DOI: 10.1186/1750-9378-5-S1-A36 |
0.701 |
|
| 2010 |
Giulino LB, Mathew S, Tam W, Chadburn A, Ballon G, Barouk S, Antonicelli G, Leoncini L, Cesarman E. TNFAIP3 (A20) Genetic Alterations In EBV Associated AIDS Related Lymphomas Blood. 116: 802-802. DOI: 10.1182/Blood.V116.21.802.802 |
0.37 |
|
| 2009 |
Chadburn A, Chiu A, Lee JY, Chen X, Hyjek E, Banham AH, Noy A, Kaplan LD, Sparano JA, Bhatia K, Cesarman E. Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5039-48. PMID 19752343 DOI: 10.1186/1750-9378-4-S2-P14 |
0.417 |
|
| 2009 |
Ma Q, Cavallin LE, Yan B, Zhu S, Duran EM, Wang H, Hale LP, Dong C, Cesarman E, Mesri EA, Goldschmidt-Clermont PJ. Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proceedings of the National Academy of Sciences of the United States of America. 106: 8683-8. PMID 19429708 DOI: 10.1073/Pnas.0812688106 |
0.427 |
|
| 2009 |
Di Bartolo DL, Hyjek E, Keller S, Guasparri I, Deng H, Sun R, Chadburn A, Knowles DM, Cesarman E. Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma. Journal of Virology. 83: 4308-15. PMID 19224997 DOI: 10.1128/Jvi.02196-08 |
0.784 |
|
| 2009 |
Chadburn A, Hyjek EM, Tam W, Liu Y, Rengifo T, Cesarman E, Knowles DM. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD). Histopathology. 53: 513-24. PMID 18983461 DOI: 10.1111/J.1365-2559.2008.03144.X |
0.418 |
|
| 2009 |
Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF. HIV-associated lymphomas and gamma-herpesviruses Blood. 113: 1213-1224. PMID 18955561 DOI: 10.1182/Blood-2008-09-180315 |
0.45 |
|
| 2008 |
Czuchlewski DR, Csernus B, Bubman D, Hyjek E, Martin P, Chadburn A, Knowles DM, Cesarman E. Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome. American Journal of Clinical Pathology. 130: 957-62. PMID 19019774 DOI: 10.1309/Ajcp12Hirwsrqlan |
0.807 |
|
| 2008 |
Lu P, Yang C, Guasparri I, Harrington W, Wang YL, Cesarman E. Early events of B-cell receptor signaling are not essential for the proliferation and viability of AIDS-related lymphoma. Leukemia. 23: 807-10. PMID 18987659 DOI: 10.1186/1750-9378-4-S2-P13 |
0.464 |
|
| 2008 |
Horenstein MG, Moontasri NJ, Cesarman E. The pathobiology of Kaposi's sarcoma: advances since the onset of the AIDS epidemic. Journal of Cutaneous Pathology. 35: 40-4. PMID 18976418 DOI: 10.1111/J.1600-0560.2008.01118.X |
0.314 |
|
| 2008 |
Mark T, Jayabalan D, Coleman M, Pearse RN, Wang YL, Lent R, Christos PJ, Lee JW, Agrawal YP, Matthew S, Ely S, Mazumdar M, Cesarman E, Leonard JP, Furman RR, et al. Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma. British Journal of Haematology. 143: 654-60. PMID 18950461 DOI: 10.1111/J.1365-2141.2008.07374.X |
0.306 |
|
| 2008 |
Guasparri I, Bubman D, Cesarman E. EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood. 111: 3813-20. PMID 18230756 DOI: 10.1182/Blood-2007-03-080309 |
0.824 |
|
| 2008 |
Brinker BT, Krown SE, Lee JY, Cesarman E, Chadburn A, Kaplan LD, Henry DH, Von Roenn JH. Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium. Cancer. 112: 1083-8. PMID 18224669 DOI: 10.1002/Cncr.23108 |
0.331 |
|
| 2008 |
Di Bartolo DL, Cannon M, Liu YF, Renne R, Chadburn A, Boshoff C, Cesarman E. KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. Blood. 111: 4731-40. PMID 18199825 DOI: 10.1182/Blood-2007-09-110544 |
0.753 |
|
| 2008 |
Ballon G, Chadburn A, Perez R, Liu Y, Sasaki Y, Cesarman E. Generation of vFLIP Transgenic Mice: A Model to Study KSHV-Associated Lymphomagenesis Blood. 112: 81-81. DOI: 10.1182/Blood.V112.11.81.81 |
0.462 |
|
| 2007 |
Bubman D, Guasparri I, Cesarman E. Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen. Oncogene. 26: 4979-86. PMID 17310999 DOI: 10.1038/Sj.Onc.1210299 |
0.797 |
|
| 2007 |
Engels EA, Mbulaiteye SM, Othieno E, Gomez M, Mathew S, Cesarman E, Knowles DM, Chadburn A. Kaposi sarcoma-associated herpesvirus in non-Hodgkin lymphoma and reactive lymphadenopathy in Uganda. Human Pathology. 38: 308-14. PMID 17097130 DOI: 10.1016/J.Humpath.2006.08.009 |
0.445 |
|
| 2007 |
Chiu A, Xu W, He B, Dillon SR, Gross JA, Sievers E, Qiao X, Santini P, Hyjek E, Lee JW, Cesarman E, Chadburn A, Knowles DM, Cerutti A. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL. Blood. 109: 729-39. PMID 16960154 DOI: 10.1182/Blood-2006-04-015958 |
0.48 |
|
| 2007 |
Wang YL, Lu P, Chung SM, Cerutti A, Song Z, Chadburn A, Tam W, Cesarman E, Knowles DM. Quantitative Assessment of DNA Editing Enzymes in B-Cell Lymphomas. Blood. 110: 4687-4687. DOI: 10.1182/Blood.V110.11.4687.4687 |
0.335 |
|
| 2007 |
Mark T, Jayabalan D, Pearse RN, Wang YL, Lent R, Christos PJ, Lee JW, Agrawal YP, Matthews S, Ely S, Mazumdar M, Cesarman E, Rambo A, Leonard JP, Coleman M, et al. Atypical Serum Immunofixation Pattern (ASIP) Development during Induction Therapy with BiRD for Newly Diagnosed Multiple Myeloma Correlates with a High Rate of Complete Remission. Blood. 110: 2737-2737. DOI: 10.1182/Blood.V110.11.2737.2737 |
0.332 |
|
| 2006 |
Cesarman E, Mesri EA. Kaposi sarcoma-associated herpesvirus and other viruses in human lymphomagenesis. Current Topics in Microbiology and Immunology. 312: 263-87. PMID 17089801 DOI: 10.1007/978-3-540-34344-8_10 |
0.515 |
|
| 2006 |
Lee JW, Chen Q, Knowles DM, Cesarman E, Wang YL. beta-Glucuronidase is an optimal normalization control gene for molecular monitoring of chronic myelogenous leukemia. The Journal of Molecular Diagnostics : Jmd. 8: 385-9. PMID 16825513 DOI: 10.2353/Jmoldx.2006.050150 |
0.311 |
|
| 2006 |
Cesarman E, Mesri EA. Pathogenesis of viral lymphomas. Cancer Treatment and Research. 131: 49-88. PMID 16704166 DOI: 10.1007/978-0-387-29346-2_2 |
0.452 |
|
| 2006 |
Wang YL, Lee JW, Cesarman E, Jin DK, Csernus B. Molecular monitoring of chronic myelogenous leukemia: identification of the most suitable internal control gene for real-time quantification of BCR-ABL transcripts. The Journal of Molecular Diagnostics : Jmd. 8: 231-9. PMID 16645210 DOI: 10.2353/Jmoldx.2006.040404 |
0.332 |
|
| 2006 |
Keller SA, Hernandez-Hopkins D, Vider J, Ponomarev V, Hyjek E, Schattner EJ, Cesarman E. NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood. 107: 3295-302. PMID 16380446 DOI: 10.1182/Blood-2005-07-2730 |
0.767 |
|
| 2006 |
Guasparri I, Wu H, Cesarman E. The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling. Embo Reports. 7: 114-9. PMID 16311516 DOI: 10.1038/Sj.Embor.7400580 |
0.425 |
|
| 2006 |
Cannon M, Cesarman E, Boshoff C. KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. Blood. 107: 277-84. PMID 16150942 DOI: 10.1182/Blood-2005-06-2350 |
0.499 |
|
| 2006 |
Guasparri I, Cesarman E. LMP1, LMP2A and CD40 Are All Essential for EBV-Associated Lymphoma Cell Survival. Blood. 108: 4353-4353. DOI: 10.1182/Blood.V108.11.4353.4353 |
0.438 |
|
| 2006 |
Di Bartolo D, Cesarman E. Inhibition of the TGFβ Pathway in Primary Effusion Lymphoma. Blood. 108: 4352-4352. DOI: 10.1182/Blood.V108.11.4352.4352 |
0.495 |
|
| 2006 |
Bubman D, Guasparri I, Cesarman E. Deregulation of c-Myc in Primary Effusion Lymphoma by KSHV LANA. Blood. 108: 4347-4347. DOI: 10.1182/Blood.V108.11.4347.4347 |
0.785 |
|
| 2006 |
Chadburn A, Chen X, Chiu A, Hyjek E, Tam W, Kaplan L, Scadden DT, Knowles DM, Cesarman E. Neither Germinal Center (GC) vs Non-Germinal Center (Non-GC) Phenotype nor FOXP1 Expression Correlate with Outcome in AIDS-Associated Diffuse Large B-Cell Lymphoma (DLBCL): Study of Patients from AIDS Malignancies Consortium Trials 010 and 034. Blood. 108: 2023-2023. DOI: 10.1182/Blood.V108.11.2023.2023 |
0.37 |
|
| 2005 |
Leonard JP, Coleman M, Kostakoglu L, Chadburn A, Cesarman E, Furman RR, Schuster MW, Niesvizky R, Muss D, Fiore J, Kroll S, Tidmarsh G, Vallabhajosula S, Goldsmith SJ. Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5696-704. PMID 16110029 DOI: 10.1200/Jco.2005.14.803 |
0.319 |
|
| 2005 |
Kaplan LD, Lee JY, Ambinder RF, Sparano JA, Cesarman E, Chadburn A, Levine AM, Scadden DT. Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood. 106: 1538-43. PMID 15914552 DOI: 10.1182/Blood-2005-04-1437 |
0.338 |
|
| 2005 |
Chang H, Gwack Y, Kingston D, Souvlis J, Liang X, Means RE, Cesarman E, Hutt-Fletcher L, Jung JU. Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTA. Journal of Virology. 79: 4651-63. PMID 15795251 DOI: 10.1128/Jvi.79.8.4651-4663.2005 |
0.47 |
|
| 2005 |
Fan W, Bubman D, Chadburn A, Harrington WJ, Cesarman E, Knowles DM. Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association. Journal of Virology. 79: 1244-51. PMID 15613351 DOI: 10.1128/Jvi.79.2.1244-1251.2005 |
0.812 |
|
| 2005 |
Bubman D, Csernus B, Guasparri I, Cesarman E. Reactive Oxygen Species (ROS) Are Induced by vFLIP and Regulate NF-kB Activation in KSHV-Infected Primary Effusion Lymphoma Cells. Blood. 106: 992-992. DOI: 10.1182/Blood.V106.11.992.992 |
0.805 |
|
| 2005 |
Leonard JP, Furman RR, Cheung YK, Feldman EJ, Cho HJ, Vose JM, Nichols G, Glynn PW, Joyce MA, Ketas J, Ruan J, Carew J, Niesvizky R, LaCasce A, Chadburn A, ... Cesarman E, et al. Phase I/II Trial of Bortezomib + CHOP-Rituximab in Diffuse Large B Cell (DLBCL) and Mantle Cell Lymphoma (MCL): Phase I Results. Blood. 106: 491-491. DOI: 10.1182/Blood.V106.11.491.491 |
0.305 |
|
| 2005 |
Chiu A, Qiao X, He B, Hyjjek E, Lee J, Cesarman E, Chadburn A, Knowles DM, Cerutti A. The TNF Family Members BAFF and APRIL Play an Important Role in Hodgkin Lymphoma. Blood. 106: 22-22. DOI: 10.1182/Blood.V106.11.22.22 |
0.48 |
|
| 2004 |
Di Bartolo D, Cesarman E. Uncovering the complexities of Kaposi's sarcoma through genome-wide expression analysis. Genome Biology. 5: 247. PMID 15535873 DOI: 10.1186/Gb-2004-5-11-247 |
0.787 |
|
| 2004 |
Chadburn A, Hyjek E, Mathew S, Cesarman E, Said J, Knowles DM. KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. The American Journal of Surgical Pathology. 28: 1401-16. PMID 15489644 DOI: 10.1097/01.Pas.0000138177.10829.5C |
0.392 |
|
| 2004 |
Guasparri I, Keller SA, Cesarman E. KSHV vFLIP is essential for the survival of infected lymphoma cells. The Journal of Experimental Medicine. 199: 993-1003. PMID 15067035 DOI: 10.1084/Jem.20031467 |
0.771 |
|
| 2004 |
Timar B, Chadburn A, Knowles D, Cesarman E. Activation of Classical and Alternative Nuclear Factor-kappaB (NF-kB) Pathways in Diffuse Large B-Cell Lymphomas. Blood. 104: 29-29. DOI: 10.1182/Blood.V104.11.29.29 |
0.469 |
|
| 2003 |
Cesarman E. Kaposi's sarcoma-associated herpesvirus--the high cost of viral survival. The New England Journal of Medicine. 349: 1107-9. PMID 13679522 DOI: 10.1056/Nejmp038125 |
0.333 |
|
| 2003 |
Bubman D, Cesarman E. Pathogenesis of Kaposi's sarcoma. Hematology/Oncology Clinics of North America. 17: 717-45. PMID 12852653 DOI: 10.1016/S0889-8588(03)00044-3 |
0.794 |
|
| 2003 |
Li Z, Pan L, Cesarman E, Knowles DM. Alterations of mRNA splicing in primary effusion lymphomas. Leukemia & Lymphoma. 44: 833-40. PMID 12802923 DOI: 10.1080/1042819031000068043 |
0.448 |
|
| 2003 |
Nador RG, Chadburn A, Gundappa G, Cesarman E, Said JW, Knowles DM. Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders. The American Journal of Surgical Pathology. 27: 293-302. PMID 12604885 DOI: 10.1097/00000478-200303000-00002 |
0.482 |
|
| 2003 |
Klein U, Gloghini A, Gaidano G, Chadburn A, Cesarman E, Dalla-Favera R, Carbone A. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood. 101: 4115-21. PMID 12531789 DOI: 10.1182/Blood-2002-10-3090 |
0.498 |
|
| 2003 |
Cannon M, Philpott NJ, Cesarman E. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells. Journal of Virology. 77: 57-67. PMID 12477810 DOI: 10.1128/Jvi.77.1.57-67.2003 |
0.502 |
|
| 2002 |
Costes V, Faumont N, Cesarman E, Rousset T, Meggetto F, Delsol G, Brousset P. Human herpesvirus-8-associated lymphoma of the bowel in human immunodeficiency virus-positive patients without history of primary effusion lymphoma. Human Pathology. 33: 846-9. PMID 12203218 DOI: 10.1053/Hupa.2002.126184 |
0.476 |
|
| 2002 |
Ablashi DV, Chatlynne LG, Whitman JE, Cesarman E. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clinical Microbiology Reviews. 15: 439-64. PMID 12097251 DOI: 10.1128/Cmr.15.3.439-464.2002 |
0.425 |
|
| 2002 |
Curreli F, Cerimele F, Muralidhar S, Rosenthal LJ, Cesarman E, Friedman-Kien AE, Flore O. Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication. Journal of Virology. 76: 5208-19. PMID 11967335 DOI: 10.1128/Jvi.76.10.5208-5219.2002 |
0.473 |
|
| 2002 |
Menke DM, Chadbum A, Cesarman E, Green E, Berenson J, Said J, Tiemann M, Parwaresch R, Thome SD. Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection. American Journal of Clinical Pathology. 117: 268-75. PMID 11863223 DOI: 10.1309/7243-Av50-Kj28-V6J9 |
0.358 |
|
| 2002 |
Cesarman E. Epstein-Barr virus (EBV) and lymphomagenesis. Frontiers in Bioscience : a Journal and Virtual Library. 7: e58-65. PMID 11815280 DOI: 10.2741/A907 |
0.476 |
|
| 2002 |
Masood R, Cesarman E, Smith DL, Gill PS, Flore O. Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor. The American Journal of Pathology. 160: 23-9. PMID 11786394 DOI: 10.1016/S0002-9440(10)64344-1 |
0.335 |
|
| 2002 |
Cesarman E. The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 159: 27-37. PMID 11785841 DOI: 10.1007/978-3-642-56352-2_4 |
0.485 |
|
| 2001 |
Bernal A, Pastore RD, Asgary Z, Keller SA, Cesarman E, Liou HC, Schattner EJ. Survival of leukemic B cells promoted by engagement of the antigen receptor. Blood. 98: 3050-7. PMID 11698290 DOI: 10.1182/Blood.V98.10.3050 |
0.749 |
|
| 2001 |
Nador RG, Milligan LL, Flore O, Wang X, Arvanitakis L, Knowles DM, Cesarman E. Expression of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor monocistronic and bicistronic transcripts in primary effusion lymphomas. Virology. 287: 62-70. PMID 11504542 DOI: 10.1006/Viro.2001.1016 |
0.405 |
|
| 2001 |
Meggetto F, Cesarman E, Mourey L, Massip P, Delsol G, Brousset P. Detection and characterization of human herpesvirus-8-infected cells in bone marrow biopsies of human immunodeficiency virus-positive patients. Human Pathology. 32: 288-91. PMID 11274637 DOI: 10.1053/Hupa.2001.22749 |
0.355 |
|
| 2001 |
Pan L, Milligan L, Michaeli J, Cesarman E, Knowles DM. Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma. The Journal of Molecular Diagnostics : Jmd. 3: 32-8. PMID 11227070 DOI: 10.1016/S1525-1578(10)60647-2 |
0.3 |
|
| 2001 |
Brousset P, Cesarman E, Meggetto F, Lamant L, Delsol G. Colocalization of the viral interleukin-6 with latent nuclear antigen-1 of human herpesvirus-8 in endothelial spindle cells of Kaposi's sarcoma and lymphoid cells of multicentric Castleman's disease. Human Pathology. 32: 95-100. PMID 11172301 DOI: 10.1053/Hupa.2001.21131 |
0.488 |
|
| 2001 |
Cerimele F, Curreli F, Ely S, Friedman-Kien AE, Cesarman E, Flore O. Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties. Journal of Virology. 75: 2435-43. PMID 11160746 DOI: 10.1128/Jvi.75.5.2435-2443.2001 |
0.464 |
|
| 2001 |
Hyjek E, Chadburn A, Liu YF, Cesarman E, Knowles DM. BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus. Blood. 97: 270-6. PMID 11133771 DOI: 10.1182/Blood.V97.1.270 |
0.332 |
|
| 2000 |
Keller SA, Schattner EJ, Cesarman E. Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood. 96: 2537-42. PMID 11001908 |
0.753 |
|
| 2000 |
Cesarman E, Mesri EA, Gershengorn MC. Viral G protein-coupled receptor and Kaposi's sarcoma: A model of paracrine neoplasia? Journal of Experimental Medicine. 191: 417-421. PMID 10662787 DOI: 10.1084/Jem.191.3.417 |
0.358 |
|
| 2000 |
Tao J, Savargaonkar P, Vallejo C, Cesarman E, Fuchs A. Aggressive natural killer cell lymphoma presenting as an anterior mediastinal mass in a patient with acquired immunodeficiency syndrome. Archives of Pathology & Laboratory Medicine. 124: 304-9. PMID 10656746 DOI: 10.1043/0003-9985(2000)124<0304:Ankclp>2.0.Co;2 |
0.451 |
|
| 2000 |
Keller SA, Schattner EJ, Cesarman E. Inhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cells Blood. 96: 2537-2542. DOI: 10.1182/Blood.V96.7.2537.H8002537_2537_2542 |
0.766 |
|
| 1999 |
Cesarman E, Mesri EA. Virus-associated lymphomas. Current Opinion in Oncology. 11: 322-32. PMID 10505767 DOI: 10.1097/00001622-199909000-00002 |
0.43 |
|
| 1999 |
Tsang P, Pan L, Cesarman E, Tepler J, Knowles DM. A distinctive composite lymphoma consisting of clonally related mantle cell lymphoma and follicle center cell lymphoma. Human Pathology. 30: 988-92. PMID 10452515 DOI: 10.1016/S0046-8177(99)90256-3 |
0.474 |
|
| 1999 |
Cannon JS, Nicholas J, Orenstein JM, Mann RB, Murray PG, Browning PJ, DiGiuseppe JA, Cesarman E, Hayward GS, Ambinder RF. Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. The Journal of Infectious Diseases. 180: 824-8. PMID 10438372 DOI: 10.1086/314956 |
0.452 |
|
| 1999 |
Said JW, Shintaku IP, Asou H, deVos S, Baker J, Hanson G, Cesarman E, Nador R, Koeffler HP. Herpesvirus 8 inclusions in primary effusion lymphoma: report of a unique case with T-cell phenotype. Archives of Pathology & Laboratory Medicine. 123: 257-60. PMID 10086517 DOI: 10.1043/0003-9985(1999)123<0257:HIIPEL>2.0.CO;2 |
0.337 |
|
| 1999 |
Keller S, Asgary Z, Cesarman E, Schattner E. INDUCTION OF FAS-MEDIATED APOPTOSIS IN KSHV+ PEL CELLS. Jaids: Journal of Acquired Immune Deficiency Syndromes. 21: A35. DOI: 10.1097/00126334-199905010-00121 |
0.711 |
|
| 1999 |
Chadburn A, Hyjeck E, Ying L, Mulligan L, Cesarman E, Knowles DM. EXPRESSION OF EPSTEIN BARR VIRUS (EBV) GENES IN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLPDs). Jaids: Journal of Acquired Immune Deficiency Syndromes. 21: A30. DOI: 10.1097/00126334-199905010-00104 |
0.327 |
|
| 1999 |
Nikolovska S, Naiyer AJ, Flore O, Peichev M, Witte L, Rafii S, Cesarman E. IN VITRO INHIBITION OF KSHV/HHV-8 INFECTED ENDOTHELIAL CELL GROWTH BY NEUTRALIZING MONOCLONAL ANTIBODIES TO HUMAN VEGFR-2 (KDR) Jaids: Journal of Acquired Immune Deficiency Syndromes. 21: A28. DOI: 10.1097/00126334-199905010-00096 |
0.333 |
|
| 1999 |
Cerimele F, Cesarman E, Curreli F, Hyjek E, Knowles DM, Flore O. IN VITRO INFECTION OF PRIMARY HUMAN KERATINOCYTES BY KAPOSI'S SARCOMA ASSOCIATED HERPESVIRUS. Jaids: Journal of Acquired Immune Deficiency Syndromes. 21: A28. DOI: 10.1097/00126334-199905010-00093 |
0.378 |
|
| 1999 |
Chadburn A, Hyjek E, Ying L, Mulligan L, Knowles DM, Cesarman E. KSHV/HHV-8 INTERLEUKIN-6 (vIL6) EXPRESSION IN HIV-RELATED LYMPHADENOPATHY CORRELATES WITH DEVELOPMENT OF KAPOSI'S SARCOMA AND SURVIVAL. Jaids: Journal of Acquired Immune Deficiency Syndromes. 21: A21. DOI: 10.1097/00126334-199905010-00067 |
0.32 |
|
| 1998 |
Matolcsy A, Nádor RG, Cesarman E, Knowles DM. Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. The American Journal of Pathology. 153: 1609-14. PMID 9811353 DOI: 10.1016/S0002-9440(10)65749-5 |
0.481 |
|
| 1998 |
Cesarman E, Chadburn A, Liu YF, Migliazza A, Dalla-Favera R, Knowles DM. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome Blood. 92: 2294-2302. PMID 9746767 DOI: 10.1182/Blood.V92.7.2294.2294_2294_2302 |
0.327 |
|
| 1998 |
Flore O, Rafii S, Ely S, O'Leary JJ, Hyjek EM, Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature. 394: 588-92. PMID 9707121 DOI: 10.1038/29093 |
0.46 |
|
| 1998 |
Geras-Raaka E, Arvanitakis L, Bais C, Cesarman E, Mesri EA, Gershengorn MC. Inhibition of constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor by protein kinases in mammalian cells in culture. The Journal of Experimental Medicine. 187: 801-6. PMID 9480990 DOI: 10.1084/Jem.187.5.801 |
0.408 |
|
| 1998 |
Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, Asch AS, Cesarman E, Gershengorn MC, Mesri EA, Gerhengorn MC. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature. 391: 86-9. PMID 9422510 DOI: 10.1038/34193 |
0.449 |
|
| 1998 |
Reed JA, Nador RG, Spaulding D, Tani Y, Cesarman E, Knowles DM. Demonstration of Kaposi's Sarcoma-Associated Herpes Virus Cyclin D Homolog in Cutaneous Kaposi's Sarcoma by Colorimetric In Situ Hybridization Using a Catalyzed Signal Amplification System Blood. 91: 3825-3832. DOI: 10.1182/Blood.V91.10.3825.3825_3825_3832 |
0.418 |
|
| 1998 |
Flore O, Hyjek E, Nikolovska S, Diana S, Rafii S, Cesarman E. CHARACTERIZATION OF KSHV/HHV-8 ACUTE INFECTION IN PRIMARY HUMAN BONE MARROW ENDOTHELIAL CELLS. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 17: A28. DOI: 10.1097/00042560-199804010-00082 |
0.325 |
|
| 1998 |
Wang X, Nador RG, Flore O, Geras-Raaka E, Gershengorn MC, Cesarman E. CHARACTERIZATION OF KSHV/HHV-8 G PROTEIN-COUPLED RECEPTOR (GPCR) TRANSCRIPTS: STRUCTURAL AND FUNCTIONAL CONSERVATION AMONG KAPOSI'S SARCOMA AND PRIMARY EFFUSION LYMPHOMA. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 17: A21. DOI: 10.1097/00042560-199804010-00056 |
0.312 |
|
| 1998 |
Chadburn A, Nador R, Cesarman E, Liu YF, Knowles DM. KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS (KSHV) INFECTION IN PROGRESSIVE HIV-RELATED LYMPHADENOPATHY (HIV-LAP). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 17: A19. DOI: 10.1097/00042560-199804010-00046 |
0.304 |
|
| 1997 |
Horenstein MG, Cesarman E, Wang X, Linkov I, Prieto VG, Louie DC. Cyclin D1 and retinoblastoma protein expression in Kaposi's sarcoma Journal of Cutaneous Pathology. 24: 585-589. PMID 9449484 DOI: 10.1111/J.1600-0560.1997.Tb01088.X |
0.319 |
|
| 1997 |
Chadburn A, Cesarman E, Nador RG, Liu YF, Knowles DM. Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus. Cancer. 80: 788-97. PMID 9264363 DOI: 10.1002/(Sici)1097-0142(19970815)80:4<788::Aid-Cncr18>3.0.Co;2-P |
0.42 |
|
| 1997 |
DePond W, Said JW, Tasaka T, de Vos S, Kahn D, Cesarman E, Knowles DM, Koeffler HP. Kaposi's sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV8)-associated lymphoma of the bowel. Report of two cases in HIV-positive men with secondary effusion lymphomas. The American Journal of Surgical Pathology. 21: 719-24. PMID 9199651 DOI: 10.1097/00000478-199706000-00013 |
0.415 |
|
| 1997 |
Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature. 385: 347-50. PMID 9002520 DOI: 10.1038/385347A0 |
0.34 |
|
| 1997 |
Horenstein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, Cesarman E. Epstein-Barr Virus Latent Gene Expression in Primary Effusion Lymphomas Containing Kaposi's Sarcoma–Associated Herpesvirus/Human Herpesvirus-8 Blood. 90: 1186-1191. DOI: 10.1182/Blood.V90.3.1186.1186_1186_1191 |
0.443 |
|
| 1997 |
Cesarman E, Nador RG, Chadbum A, Said J, Knowles DM. THE SPECTRUM OF LYMPHOMAS CONTAINING KSHV/HHV 8 Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14: A52. DOI: 10.1097/00042560-199704010-00185 |
0.346 |
|
| 1997 |
Arvanitakis L, Geras-Raaka E, Nador RG, Varma A, Gershengorn MC, Cesarman E. KSHV/HHV 8 ENCODES A CONSTITUTIVELY ACTIVE G. PROTEINCOUPLED RECEPTOR LINKED TO CELL PROLIFERATION Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14: A37. DOI: 10.1097/00042560-199704010-00125 |
0.318 |
|
| 1997 |
Reed JA, Nador RG, Knowles DM, Cesarman E. IN SITU DETECTION OF KAPOSI'S SARCOMA HERPESVIRUS / HUMAN HERPESVIRUS 8 (KSHV / HHV 8) AND EXPRESSION OF THE CYCLIN D HOMOLOG IN EARLY PATCH-STAGE LESIONS OF KAPOSI'S SARCOMA Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14: A34. DOI: 10.1097/00042560-199704010-00112 |
0.311 |
|
| 1997 |
Nador RG, Tsang P, Reed JA, Arvanitakis L, Knowles DM, Cesarman E. EXPRESSION OF KSHV/HHV 8 CYCLIN IN PRIMARY EFFUSION LYMPHOMAS AND KAPOSI'S SARCOMA Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14: A25. DOI: 10.1097/00042560-199704010-00078 |
0.414 |
|
| 1997 |
Knowles D, Cesarman E. The Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) in Kaposi's sarcoma, malignant lymphoma, and other diseases Annals of Oncology. 8: S123-S129. DOI: 10.1093/Annonc/8.Suppl_2.S123 |
0.45 |
|
| 1996 |
Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS, Chang Y, Knowles DM. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. Journal of Virology. 70: 8218-23. PMID 8892957 DOI: 10.1128/Jvi.70.11.8218-8223.1996 |
0.395 |
|
| 1996 |
Said JW, Tasaka T, Takeuchi S, Asou H, de Vos S, Cesarman E, Knowles DM, Koeffler HP. Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood. 88: 3124-8. PMID 8874212 DOI: 10.1182/Blood.V88.8.3124.Bloodjournal8883124 |
0.436 |
|
| 1996 |
Mesri EA, Cesarman E, Arvanitakis L, Rafii S, Moore MA, Posnett DN, Knowles DM, Asch AS. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. The Journal of Experimental Medicine. 183: 2385-90. PMID 8642350 DOI: 10.1084/Jem.183.5.2385 |
0.416 |
|
| 1996 |
Moore PS, Gao SJ, Dominguez G, Cesarman E, Lungu O, Knowles DM, Garber R, Pellett PE, McGeoch DJ, Chang Y. Primary characterization of a herpesvirus agent associated with Kaposi's Sarcoma Journal of Virology. 70: 549-558. PMID 8523568 DOI: 10.1128/Jvi.70.1.549-558.1996 |
0.456 |
|
| 1996 |
Said J, Tasaka T, Takeuchi S, Asou H, de Vos S, Cesarman E, Knowles D, Koeffler H. Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women Blood. 88: 3124-3128. DOI: 10.1182/blood.V88.8.3124.bloodjournal8883124 |
0.326 |
|
| 1996 |
Arvanitakis L, Mesri E, Nador R, Said J, Asch A, Knowles D, Cesarman E. Establishment and characterization of a primary effusion (body cavity- based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus Blood. 88: 2648-2654. DOI: 10.1182/Blood.V88.7.2648.Bloodjournal8872648 |
0.49 |
|
| 1996 |
Nador R, Cesarman E, Chadburn A, Dawson D, Ansari M, Sald J, Knowles D. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus Blood. 88: 645-656. DOI: 10.1182/Blood.V88.2.645.Bloodjournal882645 |
0.471 |
|
| 1996 |
Said W, Chien K, Takeuchi S, Tasaka T, Asou H, Cho S, de Vos S, Cesarman E, Knowles D, Koeffler H. Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells Blood. 87: 4937-4943. DOI: 10.1182/Blood.V87.12.4937.Bloodjournal87124937 |
0.499 |
|
| 1995 |
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (New York, N.Y.). 266: 1865-9. PMID 7997879 DOI: 10.1126/Science.7997879 |
0.307 |
|
| 1995 |
Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. The New England Journal of Medicine. 332: 1186-91. PMID 7700311 DOI: 10.1056/Nejm199505043321802 |
0.338 |
|
| 1995 |
Nador RG, Cesarman E, Knowles DM, Said JW. Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient. The New England Journal of Medicine. 333: 943. PMID 7666892 DOI: 10.1056/Nejm199510053331417 |
0.349 |
|
| 1995 |
Cesarman E, Moore P, Rao P, Inghirami G, Knowles D, Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences Blood. 86: 2708-2714. DOI: 10.1182/Blood.V86.7.2708.Bloodjournal8672708 |
0.43 |
|
| 1995 |
Frank D, Cesarman E, Liu Y, Michler R, Knowles D. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus Blood. 85: 1396-1403. DOI: 10.1182/Blood.V85.5.1396.Bloodjournal8551396 |
0.4 |
|
| 1995 |
Knowles D, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose E, Michler R. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders Blood. 85: 552-565. DOI: 10.1182/Blood.V85.2.552.Bloodjournal852552 |
0.403 |
|
| 1994 |
Inghirami G, Macri L, Cesarman E, Chadburn A, Zhong J, Knowles D. Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation Blood. 83: 3581-3590. DOI: 10.1182/Blood.V83.12.3581.3581 |
0.433 |
|
| 1994 |
Inghirami G, Macri L, Cesarman E, Chadburn A, Zhong J, Knowles D. Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation Blood. 83: 3581-3590. DOI: 10.1182/blood.v83.12.3581.3581 |
0.322 |
|
| 1992 |
Cesarman E, Chadburn A, Inghirami G, Gaidano G, Knowles D. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations Blood. 80: 3205-3216. DOI: 10.1182/Blood.V80.12.3205.Bloodjournal80123205 |
0.368 |
|
| 1987 |
Cesarman E, Dalla-Favera R, Bentley D, Groudine M. Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma Science. 238: 1272-1275. PMID 3685977 DOI: 10.1126/Science.3685977 |
0.345 |
|
| 1987 |
Dalla-Favera R, Lombardi L, Pelicci PG, Lanfrancone L, Cesarman E, Neri A. Mechanism of activation and biological role of the c-myc oncogene in B-cell lymphomagenesis Annals of the New York Academy of Sciences. 511: 207-218. PMID 2830825 DOI: 10.1111/J.1749-6632.1987.Tb36249.X |
0.381 |
|
| Show low-probability matches. |